This week, the ratings of 18 Metals and Mining stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Biotech Movers: Chelsea Doubles, Vivus Dips
Last week, Vivus slipped on a rejection from European regulators. Plus, find out why Chelsea Therapeutics and Infinity Pharmaceuticals soared. More
Fast Retailing + Gap: Would the Fishers Sell?
Rumors of a Fast Retailing/Gap merger are once again making the rounds. However, nothing will happen without the Fisher family's approval. More
NYT Says Bye to Boston Globe: A Smart Move
The New York Times Co. is looking to sell The Boston Globe and other New England properties. While the move raises some eyebrows, it looks savvy all in all. More
3 Medical Devices Stocks to Sell Now
For the current week, the overall ratings of three Medical Devices stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Berlusconi’s Pressure Cooker Effect
If Berlusconi wins in Italy, I suspect the stabilization in eurozone sovereign debt markets helped by the ECB will come to an end. More
